Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.


CIBIEM LEADERSHIP/BIOS

Ken Martin

President & CEO

Ken Martin is president and CEO of Cibiem, a medical device company dedicated to developing novel therapies for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure and diabetes.

Mark Gelfand

Chief Technical Officer

Mr. Gelfand has more than 20 years of experience developing medical devices in academic, start-up and corporate environments.

Howard R. Levin, M.D.

Chief Scientific Officer

Dr. Levin is a cardiologist and an expert in the care of patients with heart failure, heart transplantation, mechanical cardiac assistance and intensive care.

CONTACT US

5150 El Camino Real, Suite E30, Los Altos, CA 94022
phone: 650-397-6685 fax: 650-386-6125
info@cibiem.com

Cibiem Inc. 2014